Form 4: Bio-Rad Laboratories: Steven Schwartz Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Steven Schwartz, a director at Bio-Rad Laboratories, filed a Form 4 detailing changes in his beneficial ownership of company stock due to gift transactions.

Summary

  • On August 26, 2024, Steven Schwartz, a director of Bio-Rad Laboratories, reported changes in his beneficial ownership of the company's stock.
  • The filing indicates gifts of Bio-Rad B Common Stock.
  • Schwartz directly owns 362,146 shares of Bio-Rad A Common Stock.
  • Schwartz indirectly owns 1,498.0335 shares of Bio-Rad A Common Stock by spouse.
  • Schwartz indirectly owns 13,006 shares of Bio-Rad B Common Stock by spouse.
  • Schwartz indirectly owns 4,060,054 shares of Bio-Rad B Common Stock through Blue Raven Partners, L.P.
  • The reporting person disclaims beneficial ownership of shares held by spouse and Blue Raven Partners, L.P. except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock ownership changes, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
08/26/2024Date of earliest transaction (gift of Bio-Rad B Common Stock)
08/28/2024Date of signature on the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.